Roselabs Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
- Paid Up Capital ₹ 10.00 Cr
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 10.90 Cr
- Revenue Growth %
- Profit Growth -282975.11%
- Ebitda -148.28%
- Net Worth -191.74%
- Total Assets -99.73%
About Roselabs
Roselabs Limited (RL) is a Public Limited Indian Non-Government Company incorporated in India on 07 March 1995 and has a history of 29 years and 11 months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Singhal Overseas Ltd. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 10.00 Cr.
The company currently has active open charges totaling ₹10.90 Cr.
The Key Managerial Personnel (KMP) at Roselabs Limited India is Zameer Agrawal as CFO. Pawankumar Agrawal, Zameer Agrawal, Jayshree Patel, and One other member serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L51909GJ1995PLC024905
- Company No.
024905
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Mar 1995
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Roselabs?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawankumar Agrawal  | Managing Director | 03-Apr-1995 | Current |
| Zameer Agrawal | CFO | 30-Sep-2010 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Zameer Agrawal | Whole-Time Director and Cfo | 20-Mar-2009 | Current |
| Jayshree Patel | Director | 25-Feb-2015 | Current |
| Rahul Agrawal | Director | 25-Feb-2015 | Current |
Financial Performance of Roselabs.
Roselabs Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 282975.11% decrease in profit. The company's net worth observed a substantial decline by a decrease of 191.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Roselabs?
In 2021, Roselabs had a promoter holding of 63.74% and a public holding of 36.25%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Roselabs Bioscience LimitedPawankumar Agrawal, Zameer Agrawal and 1 more are mutual person
- Roselabs Polymers Limited
Pawankumar Agrawal, Zameer Agrawal and 1 more are mutual person
Rlhc Private LimitedPawankumar Agrawal is a mutual person
- Pushpdant Commotrade Private Limited
Pawankumar Agrawal and Zameer Agrawal are mutual person
- Gopalka Motor Investo Pvt. Ltd.
Pawankumar Agrawal and Zameer Agrawal are mutual person
- Garison Formulation Private Limited
Jayshree Patel and Rahul Agrawal are mutual person
Charges (Loans)
₹10.90 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 9.75 Cr
- Reliance Capital Ltd : 1.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2013 | Reliance Capital Ltd | ₹1.15 Cr | Open |
| 10 Feb 2010 | Bank Of Baroda | ₹9.50 Cr | Open |
| 10 Feb 2010 | Bank Of Baroda | ₹2.50 M | Open |
How Many Employees Work at Roselabs?
Roselabs has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Roselabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Roselabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
